Latest Derivatives News

Manuka Resources completes early-stage Mt Boppy drilling with low-grade gold results but gains key structural insights, while launching resource definition drilling at Pipeline Ridge targeting a maiden gold resource.

Manuka Resources updates its Mt Boppy exploration with low-grade gold findings and structural insights, while resource drilling at Pipeline Ridge progresses, supporting a near-term production restart.

Nelson Resources has expanded its footprint at Gold Point, Nevada, confirming multiple high-grade gold-silver mineralisation styles and staking additional claims ahead of its maiden underground drilling program.

Block, Inc. reported a robust Q1 2026 with AI-powered productivity gains, strong Cash App and Square growth, and a $5 billion share buyback boost. Despite a GAAP net loss due to restructuring and legal costs, the fintech giant raised its full-year outlook, signaling confidence in its AI-led transformation.

Hawk Resources has clinched a Mineral Exploration Agreement with Ngaanyatjarrra Traditional Owners for its Olympus Scandium Project, clearing a key hurdle ahead of planned Q2 2026 exploration. Historical data points to a significant scandium anomaly that could define a new province in Western Australia.

Advance Metals has launched its first diamond drilling campaign at the high-grade Gavilanes Silver Project in Mexico, aiming to convert a substantial Foreign Estimate into a JORC-compliant resource by year-end.

CDC Data Centres has landed Australia's largest-ever data centre contract, a 555MW deal with a US investment grade client that pushes its total contracted capacity beyond 1GW and is set to boost EBITDAF past A$1 billion in FY28.

Entropy Neurodynamics has bolstered its intellectual property portfolio with a new US provisional patent application for TRP-8803, following compelling Phase 2a data showing a 75% response rate in treatment-resistant IBS patients.

PYC Therapeutics presented Phase 1/2 data at ARVO 2026 showing encouraging safety and efficacy signals for its RNA therapies targeting rare genetic eye diseases Retinitis Pigmentosa type 11 and Autosomal Dominant Optic Atrophy.

VanEck Investments Limited has released a comprehensive replacement Product Disclosure Statement for seven Australian bond ETFs, updating key details on investment strategies, risks, fees, and regulatory frameworks.

Pure Resources has partnered with Oak Ridge National Laboratory to develop a rare earth extraction process from its Garnet Hills garnet, aiming to add critical minerals value alongside its industrial minerals business.

Noxopharm’s SOF-16 active ingredient demonstrated potent anti-inflammatory activity in patient-derived samples of systemic lupus erythematosus and rheumatoid arthritis, advancing its Sofra™ platform beyond topical applications.